$CE

Celanese (NYSE:CE) Price Target Raised to $81.00 at Citigroup

Citigroup has increased its price target for Celanese (NYSE:CE) from $75.00 to $81.00, maintaining a "buy" rating and suggesting a potential upside of 34.71%. This comes despite Celanese missing its recent quarterly earnings and revenue estimates. While analyst coverage remains mixed, other firms have also adjusted their price targets and ratings, with some recent upgrades along with earlier downgrades in response to earnings and market conditions.

Original reporting
MarketBeat · MarketBeat
Published Mar 12, 2026, 4:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 12, 2026, 5:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Celanese (NYSE:CE) Price Target Raised to $81.00 at Citigroup — source image
Decision brief

The 30-second read

$CEBullishMed
01

Why it matters

Despite earnings misses, analyst upgrades and increased price targets suggest confidence in long-term growth, possibly driven by sector recovery or strategic initiatives.

02

Market read

The news is moderately relevant for investors focusing on the chemical and manufacturing sectors, with potential short-term trading opportunities based on analyst sentiment shifts.

03

What to watch

Potential macroeconomic headwinds, supply chain disruptions, or sector-specific regulatory changes that could impact Celanese's future earnings and stock performance.

Timing: Short to medium term (1-3 months)

Background

Celanese recently reported earnings and revenue that fell short of analyst estimates, raising concerns about near-term performance.

Company-level read

Ticker impact

$CEBullishMedium confidence
Context

Primary focus of the news, directly affecting Celanese's stock valuation.

Expected impact

Moderate upward movement in CE's stock price over the next 1-3 months, estimated at approximately 8-10%.

Evidence & confidence

The price target increase indicates analyst confidence in Celanese's long-term prospects, but earnings misses introduce some uncertainty. Technical indicators and current valuation levels should be monitored for confirmation.

Market effects

Positive outlook for the chemicals and manufacturing sectors due to increased investor confidence in Celanese.

Potential uplift in North American chemical stocks; limited impact on global markets.

Moderate; reflects sector-specific optimism rather than broad market shifts.

Counterpoint

The earnings miss indicates underlying operational challenges; the price target increase may be overly optimistic. Caution is advised as short-term headwinds could suppress stock performance.

Key entities

  • Celanese Corporation

    A global chemical and specialty materials company.

  • Citigroup

    Investment bank and financial services corporation that issued the price target upgrade.

Related articles

$CELow

Celanese Corp (CE): Results of Operations and Financial Condition

Celanese Corp (CE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 q220268-kex992.htm EX-99.2 Document Exhibit 99.2 Non-U.S. GAAP Financial Measures and Supplemental Information August 4, 2026 In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis. Purpose Th

$CEMed

Celanese Corporation: Amsterdam District Court Rules in Favor of Celanese and its Co-Defendants in Shell and Repsol Cases, Dismissing All Claims

Celanese (NYSE: CE) said the Amsterdam District Court dismissed Shell Chemicals Europe’s damages claim and a Repsol entities claim seeking declaratory judgment of liability against Celanese and co-defendants. The cases stem from follow-on litigation related to a 2020 European Commission settlement over past ethylene purchases in North-Western Europe.

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).

$AVAVMedAI 8/10

Bloomberg: US to purchase anti-drone lasers for $400 million

Bloomberg reports the Pentagon will buy laser-based counter-drone systems from AeroVironment Inc. in a deal valued at at least $400 million. The contract is expected to supply the Army with dozens of Locust systems, described as an AI-enabled laser system for tracking and disabling small and medium UAVs. AeroVironment shares rose 8.1% intraday, according to the report.